Christopher David Floyd
10Patents
4h-index
12Co-inventors
53Inventor score
Filing activity: Feb 2, 1982 → Oct 8, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5314880A | Benzimidazole derivatives | Chemistry; Metallurgy | 62 | Expired |
| US6228988A | Synthesis of hydroxamic acid derivatives | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5932695A | Synthesis of hydroxamic acid derivatives | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4377697A | Imidazole hydrazone and hydrazine derivatives | Chemistry; Metallurgy | 6 | Expired |
| US5741794A | Heterocyclic sulfonamide derivatives as antagonists of PAF and angiotensin II | Chemistry; Metallurgy | 4 | Expired |
| US6103739A | Metalloproteinase inhibitors | Human Necessities | 3 | Expired |
| US5308864A | 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones and the corresponding hydroxy acids | Chemistry; Metallurgy | 3 | Expired |
| US6093798A | Synthesis of hydroxamic acid derivatives | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5849951A | Synthesis of carboxylic and hydroxamic acid derivatives | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6258851A | Metalloproteinase inhibitors | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.